Company / Total Debt
Merck & Co. Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$46.8B
FY2025
5-year range
$28.7B / $46.8B
FY2021-FY2025
Trend
+35.7%
vs FY2024
Sector context
#4 of 83
Health Care
What the data says
Among 83 Health Care companies, Merck & Co. is in the bottom 5% for total debt. Total Debt has increased for 3 consecutive years, from $28.7B in FY2022 to $46.8B in FY2025.
Based on SEC 10-K filings.
$46.8B in FY2025 with a 5-year CAGR of +13.0%. Top quartile in the Health Care sector.
Increased from $33.7B to $46.8B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 83This company $46.8B Sector average $6.2B
▼
+660.0% above sector average
Key checks
Key Insights
- Merck & Co.'s total debt has grown for 3 consecutive years.
- 5-year CAGR of +13.0%, indicating consistent growth.
- In FY2025, total debt increased 35.7% year-over-year.
- Ranks #4 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $46.8B | +35.7% |
| FY2024 | $34.5B | +2.3% |
| FY2023 | $33.7B | +17.2% |
| FY2022 | $28.7B | -6.3% |
| FY2021 | $30.7B | +21.0% |
| FY2020 | $25.4B | +11.5% |
| FY2019 | $22.7B | +14.8% |
| FY2018 | $19.8B | -7.2% |
| FY2017 | $21.4B | -12.0% |
| FY2016 | $24.3B | +1.9% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026